In melanoma, the mechanisms managing tumor-induced immune suppression encompass programmed death-ligand 1 (PD-L1) excessive expression in the tumor, and programmed death-ligand 1 positive (PD-L1+) tumor-derived exosomes. This evidence concerns the gene CD274 and neoplasm.